Tumor

Sometimes to fight one villain, you have to team up with another. It works in movies – and now, medical science. Researchers have turned to anthrax as an unlikely ally in the fight against bladder cancer, with promising results in animal tests.

Researchers from the University of Michigan have developed cancer traps that can be implanted just below the skin. In mouse tests, these traps caught biomarkers that can tell doctors if cancer is present, if it’s spreading or if it’s preparing to.

One of the most promising types of cancer treatment involves boosting the immune system’s response to the presence of cancer, and now two new mouse studies out of Yale University are reporting breakthroughs in this area.

A new imaging technique could improve treatments for tumors, by revealing which ones need to be softened up ahead of time.

In preclinical tests, scientists at Wistar Institute have developed a molecule that disrupts a protein complex vital to cancer cell survival.

A cold atmospheric plasma system designed to prevent cancer relapse has been approved for human clinical trials by the FDA.

Pancreatic cancer is one of the most deadly forms of the disease, thanks largely to the fact that the tumors tend to be much more solid. But now researchers have identified a promising new drug candidate that could linger for longer to worm its way in, and works when paired with other cancer drugs.

One of the main reasons cancer is hard to beat is because it spreads through the body. But now researchers from Vanderbilt University have developed a new technique that uses nanoparticles to enhance immune cells, helping them hunt down cancer cells migrating through the bloodstream.

The FDA has granted accelerated approval to a new cancer drug called selinexor. This pill has been found to be successful in treating multiple myeloma in patients that hadn’t had success with other treatments. But at this very early stage the drug comes with some major caveats.

Researchers have created a portable device they say can determine the efficacy of patient-specific cancer drugs with an accuracy of almost 96 percent. Teaming sensors with machine learning, the device provides rapid results, aiding the selection of better drugs while reducing potential side effects.

Cytokines are small proteins that could help fight cancer, but they're toxic to healthy cells. Now, researchers from MIT have managed to keep cytokines contained in cancer cells, attaching them with proteins that stick like Velcro.

As promising as some treatments are in lab tests, unfortunately they don’t always meet hopes when translated to the real world. Now scientists have found out why a class of cancer drugs failed in human trials, and gone on to identify another drug that could finally make the treatment work.